Počet záznamů: 1
Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans
SYS 0431273 LBL 03943^^^^^2200577^^^450 005 20240103204554.1 014 $a 000331854200005 $2 WOS 017 70
$a 10.1016/j.freeradbiomed.2013.10.003 $2 DOI 100 $a 20140905d m y slo 03 ba 101 0-
$a eng $d eng 102 $a US 200 1-
$a Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans 215 $a 10 s. 463 -1
$1 001 cav_un_epca*0256631 $1 011 $a 0891-5849 $e 1873-4596 $1 200 1 $a Free Radical Biology and Medicine $v Roč. 67, FEB (2014), s. 41-50 $1 210 $c Elsevier 610 0-
$a IDO 610 0-
$a Tumor-initiating cells 610 0-
$a Mitocans 610 0-
$a Mitochondrially targeted vitamin E succinate 700 -1
$3 cav_un_auth*0052082 $a Stapelberg $b M. $y AU $4 070 701 -1
$3 cav_un_auth*0243053 $a Zobalová $b Renata $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0302914 $a Nguyen $b M.N. $y AU $4 070 701 -1
$3 cav_un_auth*0302915 $a Walker $b T. $y AU $4 070 701 -1
$3 cav_un_auth*0226880 $a Stantic $b M. $y AU $4 070 701 -1
$3 cav_un_auth*0250930 $a Goodwin $b J. $y AU $4 070 701 -1
$3 cav_un_auth*0302916 $a Pasdar $b E.A. $y AU $4 070 701 -1
$3 cav_un_auth*0302917 $a Thai $b T. $y AU $4 070 701 -1
$3 cav_un_auth*0329197 $a Prokopová $b Kateřina $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0302918 $a Yan $b B. $y AU $4 070 701 -1
$3 cav_un_auth*0305725 $a Hall $b S. $y GB $4 070 701 -1
$3 cav_un_auth*0305726 $a de Pennington $b N. $y GB $4 070 701 -1
$3 cav_un_auth*0305727 $a Thomas $b S.R. $y AU $4 070 701 -1
$3 cav_un_auth*0282678 $a Grant $b G. $y AU $4 070 701 -1
$3 cav_un_auth*0258703 $a Štursa $b Jan $i 970/97 $j Scientific-Service Teams: Bioorganic Chemistry of Saccharides, Glycoconjugates, and Delivery Systems for Target Therapy $k 970/97 $l 970/97 $p UOCHB-X $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0305728 $a Bajziková $b Martina $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0305729 $a Meedeniya $b A.C.B. $y AU $4 070 701 -1
$3 cav_un_auth*0271606 $a Truksa $b Jaroslav $i Laboratoř nádorové rezistence $j Laboratory of Tumour Resistance $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0260860 $a Ralph $b S. J. $y AU $4 070 701 -1
$3 cav_un_auth*0305730 $a Ansorge $b O. $y GB $4 070 701 -1
$3 cav_un_auth*0243250 $a Dong $b L.-F. $y AU $4 070 701 -1
$3 cav_un_auth*0239896 $a Neužil $b Jiří $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i.
Počet záznamů: 1